Lv1
40 积分 2025-06-09 加入
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
2个月前
已完结
Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics
2个月前
已完结
Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor–Related Myocarditis
4个月前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
5个月前
已完结
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
5个月前
已完结
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
6个月前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
8个月前
已完结
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
8个月前
已完结
A systematic review of cardiovascular toxicities induced by cancer immune therapies: underlying mechanisms, clinical manifestations and therapeutic approaches
8个月前
已完结
Immunotherapy-Induced Cardiotoxicity: A Narrative Review of Real-World Case Reports, Recent Information and Clinical Evidence
8个月前
已完结
皖公网安备34019202002308
